世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Pet MRI Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Integrated, Separate, Insert, Hybrid), By Imaging Technology (Conventional, Time of Flight), By Image Acquisition, By Application, By End-User

Pet MRI Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Integrated, Separate, Insert, Hybrid), By Imaging Technology (Conventional, Time of Flight), By Image Acquisition, By Application, By End-User


The Pet MRI Market is valued at USD 181.1 million in 2025 and is projected to grow at a CAGR of 7.8% to reach USD 356.1 million by 2034. Pet MRI Market The PET/MRI market (hybrid positron emissio... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
OG Analysis
オージーアナリシス
2025年11月11日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
通常3-4営業日以内 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Pet MRI Market is valued at USD 181.1 million in 2025 and is projected to grow at a CAGR of 7.8% to reach USD 356.1 million by 2034.

Pet MRI Market

The PET/MRI market (hybrid positron emission tomography with magnetic resonance imaging) comprises integrated scanners, coils, digital PET detectors, radiopharmaceuticals, and software workflows enabling simultaneous molecular and high-contrast anatomical/functional imaging. Top applications include neuro-oncology and neurodegeneration (tumor delineation, treatment response, amyloid/tau imaging), pediatric and young-adult oncology (dose-sparing vs. PET/CT), head & neck staging, pelvic cancers (notably prostate with PSMA ligands), cardiology viability/inflammation, and research in immuno-oncology and inflammation. Recent trends emphasize digital SiPM detector blocks with time-of-flight capabilities, advanced MR-based attenuation correction (including UTE/ZTE bone mapping), motion correction and respiratory gating, AI-accelerated reconstruction/denoising, whole-body protocols with shortened table times, and theranostic care pathways linking PET/MRI phenotyping to radionuclide therapy. Growth drivers include demand for radiation-sparing imaging, sharper soft-tissue contrast in complex regions, multimodal biomarkers for precision therapy, and academic–industry consortia validating clinical utility. The competitive landscape features diversified imaging majors and emerging entrants competing on detector sensitivity, gradient performance, workflow orchestration, and service models spanning radiopharmacy logistics and protocol libraries. Differentiation increasingly comes from end-to-end ecosystems - radiotracer access, coils, AI toolkits, and oncology/cardiac protocols - plus uptime guarantees and training. Barriers remain high: capital and lifecycle cost, siting and shielding complexity, technologist cross-training, longer exam times vs. PET/CT, heterogeneous reimbursement, and radiotracer availability. Overall, PET/MRI is shifting from niche research to targeted clinical adoption where soft-tissue delineation, dose stewardship, and simultaneous multiparametric insights provide clear outcome and workflow advantages.

Pet MRI Market Key Insights

• Clinical sweet spots solidify: Neuro-oncology, head & neck, and prostate cancer show the strongest clinical rationale - leveraging MR’s soft-tissue contrast and multiparametrics with PET’s sensitivity to guide surgery, radiation, and systemic therapy.
• Radiation stewardship drives pediatrics: Dose reduction vs. PET/CT underpins pediatric oncology use; optimized protocols and faster sequences expand throughput while maintaining diagnostic confidence for longitudinal follow-up.
• Digital PET + TOF improves SNR: SiPM detectors and time-of-flight timing resolution enhance lesion detectability at lower tracer doses; deep-learning reconstruction further improves image quality and reduces scan time.
• MRAC and motion are make-or-break: Reliable bone/air modeling (UTE/ZTE), continuous table motion, and AI motion correction reduce artifacts and quantitation error - critical for therapy planning and response assessment.
• Theranostics lifts relevance: PET/MRI supports selection and monitoring for radioligand therapies (e.g., PSMA, SSTR), correlating molecular uptake with MR diffusion/perfusion to personalize dosing and timing.
• Cardiac and inflammation emerge: Simultaneous perfusion/viability/inflammation imaging with PET tracers and MR mapping (T1/T2/LGE) informs myocarditis and sarcoidosis care, broadening non-oncology use cases.
• Workflow orchestration differentiates: Auto-prescription of sequences, one-click protocols, and integrated QA reduce operator burden; vendors that bundle coils, positioning aids, and standardized reporting win hospital committees.
• Economics hinge on multi-service demand: Sites justify ROI via mixed caseloads (neuro, prostate, pediatrics, research), extended hours, and partnerships with radiopharmacy networks to stabilize tracer supply and uptime.
• Training ecosystems matter: Cross-training for PET and MRI technologists, physicist support, and remote protocol optimization improve consistency and reduce repeat scans - key in multi-site health systems.
• Evidence base expands: Prospective trials and real-world registries quantify incremental value vs. PET/CT or MRI alone, focusing on management changes, reduced additional scans, and dose/time trade-offs.

Pet MRI Market Reginal Analysis

North America

Adoption concentrates in academic medical centers, pediatric hospitals, and high-volume oncology networks. Programs emphasize prostate and neuro-oncology, with growing interest in cardiac inflammation and immuno-oncology monitoring. Reimbursement remains variable, pushing sites to blend clinical and research throughput. Partnerships with radiopharmacies and vendor service SLAs are pivotal for tracer availability and uptime; AI-assisted reconstruction helps trim exam times.

Europe

Strong HTA culture and centers of excellence advance standardized protocols, particularly in neuro-oncology and head & neck. Multinational research consortia evaluate outcome and cost–utility endpoints, guiding national procurement. Emphasis on dose stewardship and MR-based functional mapping aligns with pediatric and pelvic oncology use. Tendering favors integrated service packages, training, and lifecycle support with energy-efficient system designs.

Asia-Pacific

Installations expand in Japan, South Korea, China, Australia, and India across flagship cancer hospitals and research institutes. Pelvic oncology (PSMA) and neuro indications lead, with growing pediatric adoption. Domestic radiopharmacy capacity and local manufacturing improve tracer access and cost control. Buyers prioritize price–performance, rapid service response, and scalable protocols; government grants often underwrite early clinical research.

Middle East & Africa

Gulf medical cities and select academic hubs invest in PET/MRI to anchor comprehensive cancer and cardiac programs. Procurement stresses turnkey delivery - site planning, training, and tracer logistics. Case mixes emphasize head & neck, pelvic, and pediatric oncology, with rising cardiac inflammation evaluations. Broader regional diffusion is gradual, paced by reimbursement and radiopharmacy infrastructure.

South & Central America

Major urban cancer centers and private hospital networks lead adoption, focusing on neuro and prostate imaging. Currency and import dynamics heighten attention to total cost of ownership, uptime guarantees, and multi-year service coverage. Tracer supply agreements and shared-use models (research + clinical) support viability. Training partnerships and standardized protocols help ensure consistent image quality and reporting across networks.

Pet MRI Market Segmentation

By Product
  • Integrated
  • Separate
  • Insert
  • Hybrid

    By Imaging Technology
  • Conventional
  • Time of Flight

    By Image Acquisition
  • Sequential PET MRI Scanners
  • Simultaneous PET MRI Scanners

    By Application
  • Pre-clinical PET MRI Systems
  • Clinical PET MRI Systems

    By End-User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biopharmaceutical Companies

    Key Market players

    Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., MR Solutions Ltd., Cubresa Inc., Aspect Imaging Ltd., United Imaging Healthcare Co., Ltd., Inviscan SAS

    Pet MRI Market Analytics

    The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends. Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

    Pet MRI Market Competitive Intelligence

    The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption. Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

    Countries Covered

    • North America — Pet MRI market data and outlook to 2034
      • United States
      • Canada
      • Mexico
    • Europe — Pet MRI market data and outlook to 2034
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • BeNeLux
      • Russia
      • Sweden
    • Asia-Pacific — Pet MRI market data and outlook to 2034
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Indonesia
      • Malaysia
      • Vietnam
    • Middle East and Africa — Pet MRI market data and outlook to 2034
      • Saudi Arabia
      • South Africa
      • Iran
      • UAE
      • Egypt
    • South and Central America — Pet MRI market data and outlook to 2034
      • Brazil
      • Argentina
      • Chile
      • Peru

    * We can include data and analysis of additional countries on demand.

    Research Methodology

    This study combines primary inputs from industry experts across the Pet MRI value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

    Key Questions Addressed

  • What is the current and forecast market size of the Pet MRI industry at global, regional, and country levels?
  • Which types, applications, and technologies present the highest growth potential?
  • How are supply chains adapting to geopolitical and economic shocks?
  • What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
  • Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
  • Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
  • Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

    Your Key Takeaways from the Pet MRI Market Report

    • Global Pet MRI market size and growth projections (CAGR), 2024-2034
    • Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Pet MRI trade, costs, and supply chains
    • Pet MRI market size, share, and outlook across 5 regions and 27 countries, 2023-2034
    • Pet MRI market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
    • Short- and long-term Pet MRI market trends, drivers, restraints, and opportunities
    • Porter’s Five Forces analysis, technological developments, and Pet MRI supply chain analysis
    • Pet MRI trade analysis, Pet MRI market price analysis, and Pet MRI supply/demand dynamics
    • Profiles of 5 leading companies—overview, key strategies, financials, and products
    • Latest Pet MRI market news and developments

    Additional Support

    With the purchase of this report, you will receive
    • An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
    • 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
    • Complimentary report update to incorporate the latest available data and the impact of recent market developments.
    * The updated report will be delivered within 3 working days"

    ページTOPに戻る


    Table of Contents

    1. Table of Contents
    1.1 List of Tables
    1.2 List of Figures

    2. Global Pet MRI Market Summary, 2025
    2.1 Pet MRI Industry Overview
    2.1.1 Global Pet MRI Market Revenues (In US$ billion)
    2.2 Pet MRI Market Scope
    2.3 Research Methodology

    3. Pet MRI Market Insights, 2024-2034
    3.1 Pet MRI Market Drivers
    3.2 Pet MRI Market Restraints
    3.3 Pet MRI Market Opportunities
    3.4 Pet MRI Market Challenges
    3.5 Tariff Impact on Global Pet MRI Supply Chain Patterns

    4. Pet MRI Market Analytics
    4.1 Pet MRI Market Size and Share, Key Products, 2025 Vs 2034
    4.2 Pet MRI Market Size and Share, Dominant Applications, 2025 Vs 2034
    4.3 Pet MRI Market Size and Share, Leading End Uses, 2025 Vs 2034
    4.4 Pet MRI Market Size and Share, High Growth Countries, 2025 Vs 2034
    4.5 Five Forces Analysis for Global Pet MRI Market
    4.5.1 Pet MRI Industry Attractiveness Index, 2025
    4.5.2 Pet MRI Supplier Intelligence
    4.5.3 Pet MRI Buyer Intelligence
    4.5.4 Pet MRI Competition Intelligence
    4.5.5 Pet MRI Product Alternatives and Substitutes Intelligence
    4.5.6 Pet MRI Market Entry Intelligence

    5. Global Pet MRI Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
    5.1 World Pet MRI Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
    5.1 Global Pet MRI Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
    5.2 Global Pet MRI Sales Outlook and CAGR Growth By Imaging Technology, 2024- 2034 ($ billion)
    5.3 Global Pet MRI Sales Outlook and CAGR Growth By Image Acquisition, 2024- 2034 ($ billion)
    5.4 Global Pet MRI Sales Outlook and CAGR Growth By Application, 2024- 2034 ($ billion)
    5.5 Global Pet MRI Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
    5.6 Global Pet MRI Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

    6. Asia Pacific Pet MRI Industry Statistics – Market Size, Share, Competition and Outlook
    6.1 Asia Pacific Pet MRI Market Insights, 2025
    6.2 Asia Pacific Pet MRI Market Revenue Forecast By Product, 2024- 2034 (USD billion)
    6.3 Asia Pacific Pet MRI Market Revenue Forecast By Imaging Technology, 2024- 2034 (USD billion)
    6.4 Asia Pacific Pet MRI Market Revenue Forecast By Image Acquisition, 2024- 2034 (USD billion)
    6.5 Asia Pacific Pet MRI Market Revenue Forecast By Application, 2024- 2034 (USD billion)
    6.6 Asia Pacific Pet MRI Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
    6.7 Asia Pacific Pet MRI Market Revenue Forecast by Country, 2024- 2034 (USD billion)
    6.7.1 China Pet MRI Market Size, Opportunities, Growth 2024- 2034
    6.7.2 India Pet MRI Market Size, Opportunities, Growth 2024- 2034
    6.7.3 Japan Pet MRI Market Size, Opportunities, Growth 2024- 2034
    6.7.4 Australia Pet MRI Market Size, Opportunities, Growth 2024- 2034

    7. Europe Pet MRI Market Data, Penetration, and Business Prospects to 2034
    7.1 Europe Pet MRI Market Key Findings, 2025
    7.2 Europe Pet MRI Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
    7.3 Europe Pet MRI Market Size and Percentage Breakdown By Imaging Technology, 2024- 2034 (USD billion)
    7.4 Europe Pet MRI Market Size and Percentage Breakdown By Image Acquisition, 2024- 2034 (USD billion)
    7.5 Europe Pet MRI Market Size and Percentage Breakdown By Application, 2024- 2034 (USD billion)
    7.6 Europe Pet MRI Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
    7.7 Europe Pet MRI Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
    7.7.1 Germany Pet MRI Market Size, Trends, Growth Outlook to 2034
    7.7.2 United Kingdom Pet MRI Market Size, Trends, Growth Outlook to 2034
    7.7.2 France Pet MRI Market Size, Trends, Growth Outlook to 2034
    7.7.2 Italy Pet MRI Market Size, Trends, Growth Outlook to 2034
    7.7.2 Spain Pet MRI Market Size, Trends, Growth Outlook to 2034

    8. North America Pet MRI Market Size, Growth Trends, and Future Prospects to 2034
    8.1 North America Snapshot, 2025
    8.2 North America Pet MRI Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
    8.3 North America Pet MRI Market Analysis and Outlook By Imaging Technology, 2024- 2034 ($ billion)
    8.4 North America Pet MRI Market Analysis and Outlook By Image Acquisition, 2024- 2034 ($ billion)
    8.5 North America Pet MRI Market Analysis and Outlook By Application, 2024- 2034 ($ billion)
    8.6 North America Pet MRI Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
    8.7 North America Pet MRI Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
    8.7.1 United States Pet MRI Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.7.1 Canada Pet MRI Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.7.1 Mexico Pet MRI Market Size, Share, Growth Trends and Forecast, 2024- 2034

    9. South and Central America Pet MRI Market Drivers, Challenges, and Future Prospects
    9.1 Latin America Pet MRI Market Data, 2025
    9.2 Latin America Pet MRI Market Future By Product, 2024- 2034 ($ billion)
    9.3 Latin America Pet MRI Market Future By Imaging Technology, 2024- 2034 ($ billion)
    9.4 Latin America Pet MRI Market Future By Image Acquisition, 2024- 2034 ($ billion)
    9.5 Latin America Pet MRI Market Future By Application, 2024- 2034 ($ billion)
    9.6 Latin America Pet MRI Market Future By End-User, 2024- 2034 ($ billion)
    9.7 Latin America Pet MRI Market Future by Country, 2024- 2034 ($ billion)
    9.7.1 Brazil Pet MRI Market Size, Share and Opportunities to 2034
    9.7.2 Argentina Pet MRI Market Size, Share and Opportunities to 2034

    10. Middle East Africa Pet MRI Market Outlook and Growth Prospects
    10.1 Middle East Africa Overview, 2025
    10.2 Middle East Africa Pet MRI Market Statistics By Product, 2024- 2034 (USD billion)
    10.3 Middle East Africa Pet MRI Market Statistics By Imaging Technology, 2024- 2034 (USD billion)
    10.4 Middle East Africa Pet MRI Market Statistics By Image Acquisition, 2024- 2034 (USD billion)
    10.5 Middle East Africa Pet MRI Market Statistics By Application, 2024- 2034 (USD billion)
    10.6 Middle East Africa Pet MRI Market Statistics By End-User, 2024- 2034 (USD billion)
    10.7 Middle East Africa Pet MRI Market Statistics by Country, 2024- 2034 (USD billion)
    10.7.1 Middle East Pet MRI Market Value, Trends, Growth Forecasts to 2034
    10.7.2 Africa Pet MRI Market Value, Trends, Growth Forecasts to 2034

    11. Pet MRI Market Structure and Competitive Landscape
    11.1 Key Companies in Pet MRI Industry
    11.2 Pet MRI Business Overview
    11.3 Pet MRI Product Portfolio Analysis
    11.4 Financial Analysis
    11.5 SWOT Analysis

    12 Appendix
    12.1 Global Pet MRI Market Volume (Tons)
    12.1 Global Pet MRI Trade and Price Analysis
    12.2 Pet MRI Parent Market and Other Relevant Analysis
    12.3 Publisher Expertise
    12.2 Pet MRI Industry Report Sources and Methodology

  •  

    ページTOPに戻る

    ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

    webからのご注文・お問合せはこちらのフォームから承ります

    本レポートと同分野(医療)の最新刊レポート

    OG Analysis社の ヘルスケア・医薬品分野 での最新刊レポート

    本レポートと同じKEY WORD(pet)の最新刊レポート


    よくあるご質問


    OG Analysis社はどのような調査会社ですか?


    OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。 もっと見る


    調査レポートの納品までの日数はどの程度ですか?


    在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
    但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
    発注をする前のお問合せをお願いします。


    注文の手続きはどのようになっていますか?


    1)お客様からの御問い合わせをいただきます。
    2)見積書やサンプルの提示をいたします。
    3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
    4)データリソース社からレポート発行元の調査会社へ納品手配します。
    5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


    お支払方法の方法はどのようになっていますか?


    納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
    お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
    請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
    お客様の御支払い条件が60日以上の場合は御相談ください。
    尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


    データリソース社はどのような会社ですか?


    当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
    世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
    お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


    詳細検索

    このレポートへのお問合せ

    03-3582-2531

    電話お問合せもお気軽に

     

     

    2025/12/02 10:26

    156.70 円

    182.16 円

    209.66 円

    ページTOPに戻る